ENG/中
老虎證券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Immunovant, Inc.
30.28
0.0000
成交量:
- -
成交額:
- -
市值:
19.08億
市盈率:
-34.37
高:
30.28
開:
30.28
低:
30.28
收:
30.28
52周最高:
33.30
52周最低:
10.32
股本:
6,301.48萬
流通股本:
1,144.80萬
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-0.8810
每股收益(LYR):
-0.6309
淨資產收益率:
--
總資產收益率:
--
市淨率:
17.06
市盈率(LYR):
-47.99
資料載入中...
總覽
公司
新聞資訊
公告
Immunovant, Inc.盤中異動 股價大漲5.19%
市场透视
·
01/27
Immunovant, Inc.2025財年第三財季實現淨利潤-1.27億美元,按年減少16.51%
市场透视
·
2025/11/17
Immunovant, Inc.盤中異動 早盤股價大漲5.29%
市场透视
·
2025/11/12
Immunovant, Inc.盤中異動 早盤股價大跌5.22%報22.13美元
市场透视
·
2025/11/10
Immunovant, Inc.盤中異動 早盤股價大漲5.20%
市场透视
·
2025/10/20
Immunovant, Inc.盤中異動 早盤股價大漲5.07%
市场透视
·
2025/10/09
Immunovant, Inc.盤中異動 早盤股價大漲5.01%
市场透视
·
2025/09/22
Immunovant, Inc.盤中異動 股價大跌5.08%報16.27美元
市场透视
·
2025/09/08
Immunovant, Inc.盤中異動 大幅下挫5.17%報14.66美元
市场透视
·
2025/08/12
Immunovant, Inc.盤中異動 早盤快速下跌5.09%報15.67美元
市场透视
·
2025/08/06
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易,超低佣金,新手也能轻松开启投资。在老虎证券, 1 美元起投资美股,24/5 无时差交易美股,澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易,超低佣金,新手也能轻松开启投资。在老虎证券, 1 美元起投资美股,24/5 无时差交易美股,澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/IMVTU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"IMVTU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMVTU\",,,,,undefined,":{"symbol":"IMVTU","market":"US","secType":"STK","nameCN":"Immunovant, Inc.","latestPrice":30.277,"timestamp":1591991968314,"preClose":30.277,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":11447972,"shares":63014824,"eps":-0.881038,"marketStatus":"停牌","change":0,"latestTime":"02-11 04:00:43 EST","open":30.277,"high":30.277,"low":30.277,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.881038,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1770820200000},"marketStatusCode":1,"adr":0,"listingDate":1557460800000,"exchange":"NASDAQ","adjPreClose":30.277,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMVTU\",,,,,undefined,":{"symbol":"IMVTU","floatShares":11447972,"roa":"--","roe":"--","lyrEps":-0.630873,"shares":63014824,"dividePrice":0,"high":30.277,"amplitude":0,"preClose":30.277,"low":30.277,"week52Low":10.3174,"pbRate":"17.06","week52High":33.3,"institutionHeld":0,"latestPrice":30.277,"eps":-0.881038,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.881038,"open":30.277,"prevYearClose":24.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMVTU\",params:#limit:5,,,undefined,":[{"date":"2026-02-06","symbol":"IMVTU","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770368400000,"name":null,"time":"盤前","dateTimestamp":1770354000000,"actualEps":null},{"date":"2025-11-10","symbol":"IMVTU","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1762765200000,"name":null,"time":"盤前","dateTimestamp":1762750800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMVTU\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMVTU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMVTU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606201967","title":"Immunovant, Inc.盤中異動 股價大漲5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606201967","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606201967?lang=zh_tw&edition=fundamental","pubTime":"2026-01-27 01:54","pubTimestamp":1769450085,"startTime":"0","endTime":"0","summary":"北京时间2026年01月27日01时54分,Immunovant, Inc.股票出现波动,股价大幅上涨5.19%。Immunovant, Inc.股票所在的生物技术行业中,整体涨幅为0.78%。其相关个股中,Dermata Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大,Dermata Therapeutics, Inc.、Revelation Biosciences, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃,换手率分别为699.92%、122.26%、82.20%,振幅较大的相关个股有Dermata Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts 、Acumen Pharmaceuticals, Inc.,振幅分别为110.14%、43.46%、41.91%。Immunovant, Inc.公司简介:Immunovant Inc是一家临床阶段的免疫学公司,致力于帮助自身免疫性疾病患者恢复正常生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127015445a6af3dc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127015445a6af3dc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IMVT","IMVTW","IMVTU","BK4139","BK4585"],"gpt_icon":0},{"id":"2584640929","title":"Immunovant, Inc.2025財年第三財季實現淨利潤-1.27億美元,按年減少16.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584640929","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584640929?lang=zh_tw&edition=fundamental","pubTime":"2025-11-17 00:01","pubTimestamp":1763308861,"startTime":"0","endTime":"0","summary":"11月17日,Immunovant, Inc.公布财报,公告显示公司2025财年第三财季净利润为-1.27亿美元,同比减少16.51%;其中营业收入为0.00美元,每股基本收益为-0.73美元。从资产负债表来看,Immunovant, Inc.总负债63.25百万美元,其中短期债务0.00美元,资产负债比为0.10,流动比率为0.10。机构评级:截至2025年11月17日,当前有15家机构对Immunovant, Inc.目标价做出预测,其中目标均价为38.73美元,其中最低目标价为16.00美元,最高目标价为57.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117000121a4a5a940&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117000121a4a5a940&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVT","IMVTW","IMVTU"],"gpt_icon":0},{"id":"2583766535","title":"Immunovant, Inc.盤中異動 早盤股價大漲5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583766535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583766535?lang=zh_tw&edition=fundamental","pubTime":"2025-11-12 22:44","pubTimestamp":1762958667,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日22时44分,Immunovant, Inc.股票出现异动,股价大幅拉升5.29%。Immunovant, Inc.股票所在的生物技术行业中,整体涨幅为0.47%。Immunovant, Inc.公司简介:Immunovant Inc是一家临床阶段的免疫学公司,致力于帮助自身免疫性疾病患者恢复正常生活。消息层面,截至22时44分,《H.C. Wainwright维持Immunovant买入评级,维持目标价35美元》资讯为影响Immunovant, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112224428a6f4b9a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112224428a6f4b9a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMVTW","IMVTU","BK4588","BK4585","IMVT"],"gpt_icon":0},{"id":"2582535542","title":"Immunovant, Inc.盤中異動 早盤股價大跌5.22%報22.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582535542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582535542?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 22:39","pubTimestamp":1762785542,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时39分,Immunovant, Inc.股票出现异动,股价急速下挫5.22%。截至发稿,该股报22.13美元/股,成交量10.5238万股,换手率0.06%,振幅6.47%。Immunovant, Inc.股票所在的生物技术行业中,整体涨幅为0.67%。Immunovant, Inc.公司简介:Immunovant Inc是一家临床阶段的免疫学公司,致力于帮助自身免疫性疾病患者恢复正常生活。消息层面,截至22时39分,《H.C. Wainwright维持Immunovant买入评级,维持目标价35美元》资讯为影响Immunovant, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022390294fb9618&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022390294fb9618&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTW","IMVT","BK4139","IMVTU","BK4585","BK4588"],"gpt_icon":0},{"id":"2577892294","title":"Immunovant, Inc.盤中異動 早盤股價大漲5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577892294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577892294?lang=zh_tw&edition=fundamental","pubTime":"2025-10-20 21:38","pubTimestamp":1760967487,"startTime":"0","endTime":"0","summary":"北京时间2025年10月20日21时38分,Immunovant, Inc.股票出现异动,股价急速上涨5.20%。Immunovant, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。其相关个股中,Replimune Group, Inc.、Celcuity Inc.、Azitra Inc涨幅较大,Azitra Inc、Genprex, Inc.、Scisparc Ltd.较为活跃,换手率分别为1082.29%、343.18%、112.33%,振幅较大的相关个股有Ethzilla Corporation C/Wts 06/11/2025、Rapt Therapeutics, Inc.、Replimune Group, Inc.,振幅分别为30.27%、29.52%、18.44%。Immunovant, Inc.公司简介:Immunovant Inc是一家临床阶段的免疫学公司,致力于帮助自身免疫性疾病患者恢复正常生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102021380794d3f2f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102021380794d3f2f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMVTU","BK4588","IMVTW","IMVT","BK4585"],"gpt_icon":0},{"id":"2574214135","title":"Immunovant, Inc.盤中異動 早盤股價大漲5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574214135","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574214135?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 22:06","pubTimestamp":1760018807,"startTime":"0","endTime":"0","summary":"北京时间2025年10月09日22时06分,Immunovant, Inc.股票出现异动,股价快速拉升5.07%。Immunovant, Inc.股票所在的生物技术行业中,整体跌幅为0.29%。其相关个股中,Turn Therapeutics Inc.、Galecto, Inc.、Biodexa Pharmaceuticals Plc涨幅较大,Cdt Equity Inc.、Alaunos Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为1662.13%、999.98%、665.84%,振幅较大的相关个股有Turn Therapeutics Inc.、Galecto, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为93.79%、38.78%、26.39%。Immunovant, Inc.公司简介:Immunovant Inc是一家临床阶段的免疫学公司,致力于帮助自身免疫性疾病患者恢复正常生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009220648a45869a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009220648a45869a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTU","BK4139","BK4585","BK4588","IMVTW","IMVT"],"gpt_icon":0},{"id":"2569732255","title":"Immunovant, Inc.盤中異動 早盤股價大漲5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569732255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569732255?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 23:15","pubTimestamp":1758554101,"startTime":"0","endTime":"0","summary":"北京时间2025年09月22日23时15分,Immunovant, Inc.股票出现异动,股价大幅拉升5.01%。Immunovant, Inc.股票所在的生物技术行业中,整体涨幅为0.78%。其相关个股中,Qualigen Therapeutics, Inc.、Mbx Biosciences, Inc.、Metsera, Inc.涨幅较大,Qualigen Therapeutics, Inc.、Onconetix, Inc.、Mbx Biosciences, Inc.较为活跃,换手率分别为2764.16%、150.28%、59.35%,振幅较大的相关个股有Qualigen Therapeutics, Inc.、Mbx Biosciences, Inc.、Kodiak Sciences Inc,振幅分别为112.68%、64.50%、42.92%。Immunovant, Inc.公司简介:Immunovant Inc是一家临床阶段的免疫学公司,致力于帮助自身免疫性疾病患者恢复正常生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922231501a43cb63b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922231501a43cb63b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTU","BK4139","BK4585","BK4588","IMVTW","IMVT"],"gpt_icon":0},{"id":"2566632441","title":"Immunovant, Inc.盤中異動 股價大跌5.08%報16.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566632441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566632441?lang=zh_tw&edition=fundamental","pubTime":"2025-09-08 22:22","pubTimestamp":1757341336,"startTime":"0","endTime":"0","summary":"北京时间2025年09月08日22时22分,Immunovant, Inc.股票出现波动,股价快速下挫5.08%。截至发稿,该股报16.27美元/股,成交量24.1583万股,换手率0.14%,振幅5.54%。Immunovant, Inc.股票所在的生物技术行业中,整体跌幅为0.29%。Immunovant, Inc.公司简介:Immunovant Inc是一家临床阶段的免疫学公司,致力于帮助自身免疫性疾病患者恢复正常生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908222216951ced13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908222216951ced13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVT","BK4139","BK4585","BK4588","IMVTW","IMVTU"],"gpt_icon":0},{"id":"2558662446","title":"Immunovant, Inc.盤中異動 大幅下挫5.17%報14.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558662446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558662446?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 01:49","pubTimestamp":1754934549,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日01时49分,Immunovant, Inc.股票出现波动,股价急速跳水5.17%。Immunovant, Inc.股票所在的生物技术行业中,整体跌幅为0.37%。其相关个股中,Equillium, Inc.、Entero Therapeutics Inc.、Bioxcel Therapeutics, Inc.涨幅较大,Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为6062.13%、619.22%、369.20%,振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.,振幅分别为84.05%、74.27%、62.69%。Immunovant, Inc.公司简介:Immunovant Inc是一家临床阶段的免疫学公司,致力于帮助自身免疫性疾病患者恢复正常生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081201490994dd1cd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081201490994dd1cd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTU","BK4585","IMVT","BK4588","IMVTW","BK4139"],"gpt_icon":0},{"id":"2557830373","title":"Immunovant, Inc.盤中異動 早盤快速下跌5.09%報15.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557830373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557830373?lang=zh_tw&edition=fundamental","pubTime":"2025-08-06 22:25","pubTimestamp":1754490314,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时25分,Immunovant, Inc.股票出现异动,股价大幅下跌5.09%。截至发稿,该股报15.67美元/股,成交量10.731万股,换手率0.06%,振幅4.75%。Immunovant, Inc.股票所在的生物技术行业中,整体跌幅为0.45%。Immunovant, Inc.公司简介:Immunovant Inc是一家临床阶段的免疫学公司,致力于帮助自身免疫性疾病患者恢复正常生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622251897379ead&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622251897379ead&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMVTW","BK4585","BK4588","IMVTU","IMVT"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}